HIPRA Biotech Services

Amer, ES
Biologics mRNA
Program data pending ClinicalTrials.gov matching · Last scored 2026-03-15
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (5)

Quick Facts: HIPRA Biotech Services

Signal Score
63.0/100 (as of 2026-03-15)
Quality Compliance
Assessment pending
Headquarters
Amer, ES
Modalities
Biologics, mRNA
Active CGT Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CGT manufacturing intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesBiologics, mRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: HIPRA
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Subsidiary of HIPRA
SEC FilingsParent: HIPRA
Parent company: HIPRA
Financial assessment: 68.0/100
Capacity 58.0
1 CGT manufacturing site: Amer, ES
Modalities: Biologics, mRNA
Capacity assessment: 58.0/100
Sites: Amer, ES
Source: SEC EDGAR, press monitoring, company profiles
1 CGT manufacturing site
Recent Press5 articles
1 CGT manufacturing site: Amer, ES
Modalities: Biologics, mRNA
Capacity assessment: 58.0/100

Recent News 5 articles

capacity 2026-03-19
HIPRA Biotech Expands Biologics Capacity - Contract Pharma
HIPRA Biotech Expands Biologics Capacity  Contract Pharma
Source →
general 2026-03-16
Why is Catalonia still trapped in the “valley of death” of innovation? - Diari ARA
Why is Catalonia still trapped in the “valley of death” of innovation?  Diari ARA
Source →
capacity 2026-03-10
Biomanufacturing Strategies for Accelerated Modular Scale-Up and Supply, Upcoming Webinar Hosted by Xtalks - PR Newswire
Biomanufacturing Strategies for Accelerated Modular Scale-Up and Supply, Upcoming Webinar Hosted by Xtalks  PR Newswire
Source →
capacity 2026-03-10
Biomanufacturing Strategies for Accelerated Modular Scale-Up and Supply, Upcoming Webinar Hosted by Xtalks - The AI Journal
Biomanufacturing Strategies for Accelerated Modular Scale-Up and Supply, Upcoming Webinar Hosted by Xtalks  The AI Journal
Source →
capacity 2026-03-10
Biomanufacturing Strategies for Accelerated Modular Scale-Up and Supply, Upcoming Webinar Hosted by Xtalks - The Malaysian Reserve
Biomanufacturing Strategies for Accelerated Modular Scale-Up and Supply, Upcoming Webinar Hosted by Xtalks  The Malaysian Reserve
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Biologics CDMOs → mRNA CDMOs →